Member access

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Novartis AG    NOVN   CH0012005267

NOVARTIS AG (NOVN)

132
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Latest news on NOVARTIS AG
04/13 NOVARTIS : Farma to Implement OneKey (Cegedim Relationship Management)
04/10 NOVARTIS : Oxford BioMedica Announces Preliminary Results for the Year Ended 31 ..
04/10DJZurich Stocks See Gains
04/10 NOVARTIS : Through the art of makeup, people with rare pituitary disorders now h..
04/10 NOVARTIS : French antitrust watchdog probes Roche and Novartis over eye drug
04/10 NOVARTIS : Roche says did not collude with Novartis to restrict competition
04/10 Patent Issued for Cyclosporin Analogues
04/09 NOVARTIS : data on 19 compounds at AACR highlight strong cancer pipeline across ..
04/09 NOVARTIS : Patent Issued for Lens Design and Method for Preventing Or Slowing th..
04/09 INDIA'S SUN PHARMA PLANS GRADUAL PHA : sources
04/09DJNovartis Names New Alcon, Sandoz Division Heads -- Update
04/09 Novartis names new heads for Alcon and Sandoz divisions
04/09DJNOVARTIS : Names New Alcon, Sandoz Division Heads
04/09 NOVARTIS : appoints Jeff George as Division Head, Alcon as Kevin Buehler retires..
04/08 NOVARTIS : Two million children in Zambia receive antimalarial treatment
04/08 NOVARTIS : Sues biocon for patent breach
04/08 NOVARTIS : Files patent suit against biocon over diabetes drug galvus
04/08 NOVARTIS : ProdiGene Assigned Patent
04/08 NOVARTIS : Carnegie Mellon To Present Ricardo Dolmetsch with Andrew Carnegie Pri..
04/08 NOVARTIS : AMCo appoints Claudio Albrecht as Global Strategic Adviser
04/07 NOVARTIS : To Deliver Malaria Treatment In Zambia
04/07 NOVARTIS : and Malaria No More provide two million antimalarial treatments to ch..
04/07 NOVARTIS : Alcon Research Assigned Patent
04/07 Novartis files patent infringement suit against biocon
04/07 NOVARTIS : and Malaria No More provide two million antimalarial treatments to ch..
04/07 NOVARTIS : meningitis B vaccine Bexsero® receives FDA Breakthrough Therapy desig..
04/07 NOVARTIS : and Malaria No More provide two million antimalarial treatments to ch..
04/07 NOVARTIS : Farma to Implement OneKey (Cegedim Relationship Management)
04/04 BIOCON : rejects Novartis patent infringement charge
04/03DJADR Shares End Lower; Vodafone Shares Active
04/03 NOVARTIS : data on 19 compounds at AACR highlight strong cancer pipeline across ..
04/03 NOVARTIS : Video Advisory (April 3) Novartis scandal
04/03 NOVARTIS : $542.23 Million Federal Contract Awarded to Novartis Vaccines & Diagn..
04/03 NOVARTIS : Alcon Research Assigned Patent
04/03 NOVARTIS : top management quits over involvement in clinical study
04/03 NOVARTIS : data on 19 compounds at AACR highlight strong cancer pipeline across ..
04/02 NOVARTIS : Announces FDA Approval of Xolair® omalizumab for Chronic Idiopathic U..
04/02DJADR Shares End Higher; Noah Education Shares Active
04/02 NOVARTIS : study published in NEJM showed LDK378 demonstrated an overall respons..
04/02 NOVARTIS : reports new Phase III data showing secukinumab AIN457 improved modera..
04/02 Sanofi eyes more acquisitions, sees growth in Africa
04/02 NOVARTIS : Patent Issued for Gas Pressure Monitor for Pneumatic Surgical Machine
04/02 NOVARTIS : Pharma employees suspected of privacy law violation
03/31DJADR Shares End Higher; ING, Novartis Shares Active
03/31DJEuropean Stocks End Mixed After Inflation, France Jitters
03/31DJEUROPE MARKETS : European Stocks End Mixed On Inflation Jitters
03/31DJTEVA PHARMACEUTICAL : Supreme Court to Review Teva Appeal in Copaxone Patent Cas..
03/31DJEUROPE MARKETS : European Stocks Push Higher After Weak Inflation
03/31 NOVARTIS : Effectiveness prompts Novartis to end drug study
03/31 NOVARTIS : Alcon Research Assigned Patent
03/31 GENVEC : Reports Fourth Quarter and 2013 Year-End Financial Results
03/31DJEUROPE MARKETS : European Stocks Pare Gains After Weak Inflation Data
03/31DJEUROPE MARKETS : European Stocks Firm Ahead Of Inflation Data
03/31DJNOVARTIS : Heart Failure Pill Trial Ends Early on Positive Result
03/31 NOVARTIS : PARADIGM-HF trial of Novartis' LCZ696 for chronic heart failure close..
03/30 TRANSGENE : Reports Fiscal Year 2013 Results and Supplies Business Update
03/28 NOVARTIS : Animal rights campaigner: 'I'm a scapegoat'
03/28 NOVARTIS : Vas Narasimhan to lead Sandoz' biosimilars business
03/27 NOVARTIS : to work with FDA on path forward for RLX030 for acute heart failure f..
03/27 NOVARTIS : Transgene Reports Fiscal Year 2013 Results and Provides Business Upda..
03/27 NOVARTIS : FDA Staff Says Novartis' Serelaxin Shouldn't Be Approved
03/27 NOVARTIS : Patent Issued for Method of Separating Excess Lens Forming Material f..
03/26 NOVARTIS : Patent Issued for Pyrimidylaminobenzamide Derivatives for Systemic Ma..
03/26 NOVARTIS : "Process for Manufacturing an Ophthalmic Lens" in Patent Application ..
03/26 NOVARTIS : Investigators from Novartis Institute for Biomedical Research Target ..
03/26 NOVARTIS : study published in NEJM showed LDK378 demonstrated an overall respons..
03/26 NOVARTIS : Health and Human Services Department (HHS); Food and Drug Administrat..
03/26 EXCLUSIVE - BAXTER EXPLORES SALE OF : sources
03/26DJEUROPE MARKETS : Europe Stocks Higher As ECB Stokes Stimulus Hopes
03/26 NOVARTIS : Patent Issued for Substituted Amino Bisphenyl Pentanoic Acid Derivati..
03/26 NOVARTIS : announces start of new secukinumab versus Stelara phase IIIb head-to-..
03/26 NOVARTIS : UK recommends Novartis Bexsero vaccine for inclusion in National Immu..
03/26 NOVARTIS : New phase III psoriasis data show rapid, significant skin clearance a..
03/25 NOVARTIS : Reports FDA Approval of Xolair for Chronic Idiopathic Urticaria
03/24 NOVARTIS : Health and Human Services Department (HHS); Food and Drug Administrat..
Prev.1   2  3  4  5  6  7  8  9  10Next
Advertisement
Chart
Duration : Period :
Novartis AG Technical Analysis Chart | NOVN | CH0012005267 | 4-Traders
Income Statement Evolution
Novartis AG : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF